Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:50:02 EST Sat 13 Dec 2025
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:BCDA - BIOCARDIA INC - http://www.biocardia.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
BCDA - Q0.11.40·2.920.31.45-0.02-1.437.1442351.4712  1.48  1.41013.20  1.0019:30:52Dec 0315 min RT 2¢

Recent Trades - Last 10 of 235
Time ETExPriceChangeVolume
19:30:52Q1.4589-0.01111
17:37:05Q1.46-0.011
16:00:02Q1.45-0.02869
16:00:02Q1.45-0.02100
16:00:02Q1.45-0.023
16:00:02Q1.45-0.0261
15:59:50Q1.480.0141
15:59:50Q1.47 11
15:59:48Q1.47 25
15:59:48Q1.46-0.0147

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-12-03 08:00U:BCDANews ReleaseBioCardia Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno
2025-12-01 08:30U:BCDANews ReleaseBioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress
2025-11-24 08:15U:BCDANews ReleaseBioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality
2025-11-12 16:40U:BCDANews ReleaseBioCardia Reports Third Quarter 2025 Business Highlights and Financial Results
2025-11-10 08:30U:BCDANews ReleaseBioCardia Announces Henry Ford Health Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial
2025-11-05 19:29U:BCDANews ReleaseBioCardia to Host Q3 2025 Corporate Update and Financial Results Conference Call on November 12, 2025
2025-10-30 08:00U:BCDANews ReleaseBioCardia Announces University of Wisconsin Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial
2025-10-02 08:00U:BCDANews ReleaseBioCardia Regains Compliance with Nasdaq Listing Requirements
2025-09-22 08:00U:BCDANews ReleaseBioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure
2025-09-18 09:15U:BCDANews ReleaseBioCardia Announces Pricing of Up To $12 Million Public Offering
2025-09-18 07:00U:BCDANews ReleaseBioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance and Reduced Angina Episodes at Six-Month Primary Follow-up
2025-09-04 09:00U:BCDANews ReleaseBioCardia CEO Peter Altman to Present at the H. C. Wainwright 27th Annual Global Investment Conference in New York City September 8-10, 2025
2025-08-13 08:00U:BCDANews ReleaseBioCardia and CART-Tech Announce Exclusive Partnership to Develop and Commercialize Heart3D(TM) Fusion Imaging for Interventional Cardiology
2025-08-11 09:15U:BCDANews ReleaseBioCardia Reports Second Quarter 2025 Business Highlights and Financial Results
2025-08-06 15:18U:BCDANews ReleaseBioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025
2025-08-04 06:00U:BCDANews ReleaseBioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP(TM) Cell Therapy for Heart Failure and Helix(TM) Transendocardial Delivery Catheter
2025-07-24 09:00U:BCDANews ReleaseBioCardia Submits Request for Clinical Data Review Meeting with Japan PMDA To Discuss Approval Pathway for CardiAMP(TM) Cell Therapy in Ischemic Heart Failure
2025-07-16 08:45U:BCDANews ReleaseHenry Ford Health Initiates Patient Enrollment for BioCardia's CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction
2025-06-25 08:00U:BCDANews ReleaseBioCardia Announces New United States Patent for Helix Biotherapeutic Delivery System
2025-05-21 08:30U:BCDANews ReleaseBioCardia to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21, 2025